Mark W. Harty

1.2k citations
20 papers · 982 indexed · h-index 14

Mark W. Harty

20 papers receiving 964 citations

Peers

Mark W. Harty
Comparison fields: 5 of 101
  • Rehabilitation 112
  • Hepatology 111
  • Immunology 280
  • Hematology 112
  • Developmental Neuroscience 24
Replace Anuradha Natarajan with:
Anuradha Natarajan Austria
Scott Swanson United States
Ross Dobie United Kingdom
Luigi Maddaluno Italy
Dominique Daegelen France
Kathleen Kelly United States
Shentong Fang Finland
Helene Klapper United States
Svetlana N. Popova Sweden
Alexandre Trindade Portugal
Mark W. Harty relative to Anuradha Natarajan Austria Anuradha Natarajan's profile →
Citations per field
00.5×5.9×
Anuradha Natarajan · 1×
Citations per year

Countries citing papers authored by Mark W. Harty

Since Specialization
Citations

This map shows the geographic impact of Mark W. Harty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Harty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Harty more than expected).

Fields of papers citing papers by Mark W. Harty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Harty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Harty. The network helps show where Mark W. Harty may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark W. Harty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark W. Harty Line = papers co-authored together Mark W. Harty links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 201051
3 200994
4 20096
5 200811
6 200833
7 200732
8 200776
9 200695
10 200537
11 200537
12 2003196
13 200339
14 200329
15 19983
16 199849
17 19949
18
Selective inhibition of CD4 graft-versus-host activity in IL-2-treated mice.
19933
19 199387
20 199394

About Mark W. Harty

Mark W. Harty is a scholar working on Hepatology, Developmental Biology and Rehabilitation, having authored 20 papers that have together received 982 indexed citations. Recurring topics across this work include Liver physiology and pathology (4 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers), Organ Transplantation Techniques and Outcomes (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Developmental Biology and Gene Regulation (3 papers), Wound Healing and Treatments (2 papers), Spinal Cord Injury Research (2 papers) and Nerve injury and regeneration (2 papers). The work is most often cited by research in Rehabilitation (112 citations), Hepatology (111 citations) and Immunology (280 citations). Mark W. Harty has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Anthony L. Mescher, Michael W. King, Anton W. Neff, Megan Sykes, D. A. Pearson, Thomas F. Tracy, Elaine Papa, Varghese Abraham, Stephan Gehring and Gregory L. Szot. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Immunology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026